These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 35169512)
21. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness? Perera C; Patterson S; Bruxner G Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123 [TBL] [Abstract][Full Text] [Related]
22. Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial. Bersudsky Y; Applebaum J; Gaiduk Y; Sharony L; Mishory A; Podberezsky A; Agam G; Belmaker RH Bipolar Disord; 2010 Jun; 12(4):376-82. PubMed ID: 20636634 [TBL] [Abstract][Full Text] [Related]
23. Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience-a European perspective. Toledo M; Mostacci B; Bosak M; Jedrzejzak J; Thomas RH; Salas-Puig J; Biraben A; Schmitz B J Neurol; 2021 Aug; 268(8):2735-2748. PubMed ID: 32239268 [TBL] [Abstract][Full Text] [Related]
24. Awareness, knowledge and practice of healthcare professionals following implementation of a Pregnancy Prevention Program for sodium valproate in Ireland: a multi-stakeholder cross-sectional study. Hughes JE; Buckley N; Looney Y; Kirwan G; Curran S; Doherty CP; Mullooly M; Bennett KE Expert Opin Drug Saf; 2021 Aug; 20(8):965-977. PubMed ID: 34080507 [TBL] [Abstract][Full Text] [Related]
25. Sodium valproate induced acute pancreatitis in a bipolar disorder patient: a case report. Huang W; Ren X; Shen F; Xing B BMC Pharmacol Toxicol; 2019 Nov; 20(1):71. PubMed ID: 31783774 [TBL] [Abstract][Full Text] [Related]
26. A review of valproate in psychiatric practice. Haddad PM; Das A; Ashfaq M; Wieck A Expert Opin Drug Metab Toxicol; 2009 May; 5(5):539-51. PubMed ID: 19409030 [TBL] [Abstract][Full Text] [Related]
27. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171 [TBL] [Abstract][Full Text] [Related]
28. Sodium valproate and the fetus: a case study and review of the literature. Smith J; Whitehall J Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633 [TBL] [Abstract][Full Text] [Related]
29. Effect size of lithium, carbamazepine, and sodium valproate in child and adolescent bipolar 1 disorder during manic phase: A prospective open-label study. Singh RK; Sinha VK; Chaudhury S Ind Psychiatry J; 2019; 28(2):185-197. PubMed ID: 33223710 [TBL] [Abstract][Full Text] [Related]
30. Awareness and documentation of the teratogenic effects of valproate among women of child-bearing potential. Mulryan D; McIntyre A; McDonald C; Feeney S; Hallahan B BJPsych Bull; 2018 Dec; 42(6):233-237. PubMed ID: 30109830 [TBL] [Abstract][Full Text] [Related]
31. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC Int Clin Psychopharmacol; 2003 Mar; 18(2):73-9. PubMed ID: 12598817 [TBL] [Abstract][Full Text] [Related]
32. Best practice guidelines for the management of women with epilepsy. Crawford P Epilepsia; 2005; 46 Suppl 9():117-24. PubMed ID: 16302885 [TBL] [Abstract][Full Text] [Related]
33. Pregnancy outcome after in utero exposure to valproate : evidence of dose relationship in teratogenic effect. Diav-Citrin O; Shechtman S; Bar-Oz B; Cantrell D; Arnon J; Ornoy A CNS Drugs; 2008; 22(4):325-34. PubMed ID: 18336060 [TBL] [Abstract][Full Text] [Related]
34. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review]. Munch G; Godart N Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720 [TBL] [Abstract][Full Text] [Related]
35. Bipolar disorder in women: reproductive events and treatment considerations. Freeman MP; Gelenberg AJ Acta Psychiatr Scand; 2005 Aug; 112(2):88-96. PubMed ID: 15992389 [TBL] [Abstract][Full Text] [Related]
36. Treatment decisions in women of childbearing age on valproate. Harris L; Lowes O; Angus-Leppan H Acta Neurol Scand; 2020 Apr; 141(4):287-293. PubMed ID: 31883101 [TBL] [Abstract][Full Text] [Related]
37. Valproate prescriptions for nonepilepsy disorders in reproductive-age women. Adedinsewo DA; Thurman DJ; Luo YH; Williamson RS; Odewole OA; Oakley GP Birth Defects Res A Clin Mol Teratol; 2013 Jun; 97(6):403-8. PubMed ID: 23733498 [TBL] [Abstract][Full Text] [Related]
38. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential. Serafini A; Gerard E; Genton P; Crespel A; Gelisse P CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367 [TBL] [Abstract][Full Text] [Related]
39. Valproate in acute mania: is our practice evidence based? Vasudev K; Mead A; Macritchie K; Young AH Int J Health Care Qual Assur; 2012; 25(1):41-52. PubMed ID: 22455007 [TBL] [Abstract][Full Text] [Related]